Learn about Dr. Mwimanzi’s CTN Postdoctoral Fellowship project, studying the immune response to COVID-19 vaccines among people living with HIV
Understanding COVID-19 vaccine confidence in people living with HIV in Canada
As provinces across Canada begin to roll out third doses of COVID-19 vaccines, information about who qualifies for additional or booster doses is coming at us faster than you can say immunocompromised. But are we immunocompromised? Do we need a booster or a third dose? Is there a difference?
A new national study, called HIVCOV (CTN 328), will assess COVID-19 vaccine immune responses and effectiveness among people living with HIV
New funding for CTN 300-2 will allow the study team to document COVID-19 infection, immunity, and related determinants in gay, bisexual, and other men who have sex with men
Our Resource Library is a place to share documents, videos, and training resources about HIV and STBBI research and related topics.
There are no results message
The CTN+ supports clinical trials, implementation science projects, and non-interventional research of the highest scientific and ethical standards.
Immunogenicity outcomes in people living with HIV following vaccination for COVID-19 (HIV-COV)
The impact of COVID-19 on persons with HIV in Canada: Data from the HIV/HCV co-infection/CCC (CTN 222) and HIV aging cohorts (CTN 314)
Our researchers and trainees have produced hundreds of peer-reviewed publications in a wide range of HIV- and STBBI-related areas.